In this episode, host Jeremy Schrand is joined by Tim Schroeder, Chairman, CEO, and Founder of CTI, and Joel White, Owner of Marketcap Consulting, for a broad discussion on the clinical research industry. Topics include recent industry developments, biotech funding challenges, leadership in clinical trials, corporate citizenship, and predictions for future innovation.
01:20 Tim shares insights on the current state ofthe clinical research industry, highlighting recent developments and a view toward stability and cautious optimism.
02:36 Joe discusses macro trends shaping the clinical research landscape, focusing on biotech funding challenges and the impact on the industry.
04:05 The conversation shifts to the pharma services sector, with Joe reflecting on the changing number of public companies and the influence of major investment firms.
06:53 The conversation explores industry cancellation rates and repeat business, leading to a discussion on measurement differences and the challenges of consistent reporting.
08:08 The role of leadership in navigating today's complex clinical trial environment is explored, emphasizing vision, talent retention, and cultural impact.
13:08 Tim and Joel discuss corporate citizenship, leading to reflections on CTI’s evolution, community involvement, and the importance of sustainability.
21:01 Exploring the potential influence of major retail companies on the clinical trial ecosphere, the conversation considers their resources and the challenges they face within the industry.
22:34 Tim addresses therapeutic areas with recent surges in activity or innovation, prompting a discussion on oncology,neurodegeneration, and GLP therapies.
29:00 Bold predictions shape the future of the clinical research industry, with forecasts pointing to a recovery in biotech funding and shifts in FDA approval processes.
